The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Brevibloc Premixed 10 mg/ml Solution for Infusion



Baxter Holding B.V.PA2299/021/002

Main Information

Trade NameBrevibloc Premixed 10 mg/ml Solution for Infusion
Active SubstancesESMOLOL HYDROCHLORIDE
Dosage FormSolution for infusion
Licence HolderBaxter Holding B.V.
Licence NumberPA2299/021/002

Group Information

ATC CodeC07AB Beta blocking agents, selective
C07AB09 esmolol

Status

License statusAuthorised
Licence Issued10/12/2010
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceNone
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back